The novel nomogram predictive model, based on preoperative clinicopathological factors such as tumor size, histological type, presence of ulcers, and HAVCR1 expression, provides valuable guidance for selecting treatment strategies for EGC patients. This evidence concerns the gene HAVCR1 and neoplasm.